Annual ROE:
-54.83%+14.88%(+21.35%)Summary
- As of today, TARS annual return on equity is -54.83%, with the most recent change of +14.88% (+21.35%) on December 31, 2024.
- During the last 3 years, TARS annual ROE has fallen by -46.52% (-559.81%).
- TARS annual ROE is now -559.81% below its all-time high of -8.31%, reached on December 31, 2021.
Performance
TARS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-33.11%+6.29%(+15.96%)Summary
- As of today, TARS quarterly return on equity is -33.11%, with the most recent change of +6.29% (+15.96%) on June 30, 2025.
- Over the past year, TARS quarterly ROE has increased by +35.99% (+52.08%).
- TARS quarterly ROE is now -175.37% below its all-time high of 43.93%, reached on March 31, 2020.
Performance
TARS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TARS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +21.4% | +52.1% |
| 3Y3 Years | -559.8% | -6.5% |
| 5Y5 Years | -249.9% | -190.9% |
TARS ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -559.8% | +21.4% | at high | +55.0% |
| 5Y | 5-Year | -559.8% | +21.4% | -934.7% | +55.0% |
| All-Time | All-Time | -559.8% | +21.4% | -175.4% | +55.0% |
TARS ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -33.11%(+16.0%) |
| Mar 2025 | - | -39.40%(+19.1%) |
| Dec 2024 | -54.83%(+21.3%) | -48.70%(+14.8%) |
| Sep 2024 | - | -57.14%(+17.3%) |
| Jun 2024 | - | -69.10%(+6.1%) |
| Mar 2024 | - | -73.59%(-0.1%) |
| Dec 2023 | -69.71%(-101.9%) | -73.48%(-27.1%) |
| Sep 2023 | - | -57.82%(-19.3%) |
| Jun 2023 | - | -48.47%(-39.6%) |
| Mar 2023 | - | -34.73%(-4.4%) |
| Dec 2022 | -34.53% | -33.28%(+3.4%) |
| Sep 2022 | - | -34.46%(-10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -31.09%(-21.7%) |
| Mar 2022 | - | -25.54%(-224.5%) |
| Dec 2021 | -8.31%(+65.4%) | -7.87%(-20.0%) |
| Sep 2021 | - | -6.56%(-105.0%) |
| Jun 2021 | - | -3.20%(+65.1%) |
| Mar 2021 | - | -9.17%(+60.6%) |
| Dec 2020 | -24.01%(-53.2%) | -23.28%(+15.5%) |
| Sep 2020 | - | -27.55%(-142.1%) |
| Jun 2020 | - | -11.38%(-125.9%) |
| Mar 2020 | - | 43.93%(+287.4%) |
| Dec 2019 | -15.67%(+73.7%) | 11.34% |
| Dec 2018 | -59.68% | - |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of TARS is -54.83%
What is the all-time high annual ROE for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual return on equity is -8.31%
What is Tarsus Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, TARS annual return on equity has changed by +14.88% (+21.35%)
What is Tarsus Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of TARS is -33.11%
What is the all-time high quarterly ROE for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly return on equity is 43.93%
What is Tarsus Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, TARS quarterly return on equity has changed by +35.99% (+52.08%)